Cargando…
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984662/ https://www.ncbi.nlm.nih.gov/pubmed/24615514 http://dx.doi.org/10.1007/s00401-014-1265-3 |
| _version_ | 1782311462576848896 |
|---|---|
| author | Levin, Johannes Schmidt, Felix Boehm, Cathrin Prix, Catharina Bötzel, Kai Ryazanov, Sergey Leonov, Andrei Griesinger, Christian Giese, Armin |
| author_facet | Levin, Johannes Schmidt, Felix Boehm, Cathrin Prix, Catharina Bötzel, Kai Ryazanov, Sergey Leonov, Andrei Griesinger, Christian Giese, Armin |
| author_sort | Levin, Johannes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3984662 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39846622014-04-23 The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset Levin, Johannes Schmidt, Felix Boehm, Cathrin Prix, Catharina Bötzel, Kai Ryazanov, Sergey Leonov, Andrei Griesinger, Christian Giese, Armin Acta Neuropathol Correspondence Springer Berlin Heidelberg 2014-03-11 2014 /pmc/articles/PMC3984662/ /pubmed/24615514 http://dx.doi.org/10.1007/s00401-014-1265-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
| spellingShingle | Correspondence Levin, Johannes Schmidt, Felix Boehm, Cathrin Prix, Catharina Bötzel, Kai Ryazanov, Sergey Leonov, Andrei Griesinger, Christian Giese, Armin The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title | The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title_full | The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title_fullStr | The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title_full_unstemmed | The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title_short | The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset |
| title_sort | oligomer modulator anle138b inhibits disease progression in a parkinson mouse model even with treatment started after disease onset |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984662/ https://www.ncbi.nlm.nih.gov/pubmed/24615514 http://dx.doi.org/10.1007/s00401-014-1265-3 |
| work_keys_str_mv | AT levinjohannes theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT schmidtfelix theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT boehmcathrin theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT prixcatharina theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT botzelkai theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT ryazanovsergey theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT leonovandrei theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT griesingerchristian theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT giesearmin theoligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT levinjohannes oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT schmidtfelix oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT boehmcathrin oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT prixcatharina oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT botzelkai oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT ryazanovsergey oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT leonovandrei oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT griesingerchristian oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset AT giesearmin oligomermodulatoranle138binhibitsdiseaseprogressioninaparkinsonmousemodelevenwithtreatmentstartedafterdiseaseonset |